To correct technical errors in the enrollment of the bill H.R. 3580.
The source supplies the latest action, but no lifecycle stage.
Latest action (8 Nov 2007): Referred to the Subcommittee on Health.
What this bill does
This House Concurrent Resolution, H. Con. Res. 217, proposes to make specific corrections to a previously passed bill, H.R. 3580. These changes involve amending language in two sections of federal law, the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act. The proposed amendments would add the word "devices" to one section and insert a new sentence clarifying the process for considering certain petitions in another.
The resolution specifically targets technical errors found during the enrollment of H.R. 3580, which is the final step of preparing a bill after it has been approved by both the House and Senate. The corrections would affect how certain "drugs and devices" are described and how the review of petitions related to applications under the Federal Food, Drug, and Cosmetic Act is handled.
H. Con. Res. 217 was introduced in the House of Representatives on September 24, 2007, by Representative John D. Dingell. It was referred to committees and has since been referred to the Subcommittee on Health. As a concurrent resolution, its purpose is to recommend actions or express the sense of Congress, and it does not require the President's signature to become effective. The next step in the process would typically involve the subcommittee reviewing the resolution.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
8 Nov 2007
Referred to the Subcommittee on Health.
Common questions
- What does H.Con.Res. 217 do?
- This House Concurrent Resolution, H. Con. Res. 217, proposes to make specific corrections to a previously passed bill, H.R. 3580. These changes involve amending language in two sections of federal law, the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act. The proposed amendments would add the word "devices" to one section and insert a new sentence clarifying the process for considering certain petitions in another. The resolution specifically targets technical errors found during the enrollment of H.R. 3580, which is the final step of preparing a bill after it has been approved by both the House and Senate. The corrections would affect how certain "drugs and devices" are described and how the review of petitions related to applications under the Federal Food, Drug, and Cosmetic Act is handled. H. Con. Res. 217 was introduced in the House of Representatives on September 24, 2007, by Representative John D. Dingell. It was referred to committees and has since been referred to the Subcommittee on Health. As a concurrent resolution, its purpose is to recommend actions or express the sense of Congress, and it does not require the President's signature to become effective. The next step in the process would typically involve the subcommittee reviewing the resolution.
- Has H.Con.Res. 217 become law?
- The source does not supply a confirmed lifecycle stage for H.Con.Res. 217. Check the latest action and official source below.
- Who sponsored H.Con.Res. 217?
- H.Con.Res. 217 was sponsored by Rep. Dingell, John D. [D-MI-15] (D-MI), with 1 cosponsor.
- What's the latest action on H.Con.Res. 217?
- Referred to the Subcommittee on Health. (8 Nov 2007).
Related bills in Congress
Providing for consideration of the bill (H.R. 9899) to designate Afghanistan under section 244 of the Immigration and Nationality Act to permit nationals of Afghanistan to be eligible for temporary protected status under such section, and for other purposes.
Expressing profound sorrow over the death of Alexander Michel Odeh.
Stop Insider Trading Act
A resolution relating to the death of the Honorable Nancy Kassebaum, former United States Senator for the State of Kansas.
More bills from Rep. Dingell, John D. [D-MI-15]
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.